White matter hyperintensities in Alzheimer's disease in the era of anti-amyloid therapies.

Garnier-Crussard A, Dadar M, Villain N, Charidimou A, Boulouis G, Cotton F, Brickman AM, Chételat G

Open source

DOI
10.1002/dad2.70349
Published
2026 Apr-Jun
Container
Alzheimer's & dementia (Amsterdam, Netherlands)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/dad2.70349,
  title = {White matter hyperintensities in Alzheimer's disease in the era of anti-amyloid therapies.},
  author = {Garnier-Crussard A and Dadar M and Villain N and Charidimou A and Boulouis G and Cotton F and Brickman AM and Chételat G},
  year = {2026},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  doi = {10.1002/dad2.70349},
  url = {https://doi.org/10.1002/dad2.70349}
}

RIS

TY  - JOUR
TI  - White matter hyperintensities in Alzheimer's disease in the era of anti-amyloid therapies.
AU  - Garnier-Crussard A
AU  - Dadar M
AU  - Villain N
AU  - Charidimou A
AU  - Boulouis G
AU  - Cotton F
AU  - Brickman AM
AU  - Chételat G
PY  - 2026
JO  - Alzheimer's & dementia (Amsterdam, Netherlands)
DO  - 10.1002/dad2.70349
UR  - https://doi.org/10.1002/dad2.70349
ER  - 

APA

A, G., M, D., N, V., A, C., G, B., F, C., AM, B., & G, C. (2026). White matter hyperintensities in Alzheimer's disease in the era of anti-amyloid therapies.. Alzheimer's & dementia (Amsterdam, Netherlands). https://doi.org/10.1002/dad2.70349

Source records